Will the Phase 2 trial "A Prospective Phase II Study of Postoperative Concurrent Chemoradiotherapy in Patients With Intrahepatic Cholangiocarcinoma" reach primary completion on or before May 15, 2028?

Resolves Yes if ClinicalTrials.gov record NCT07063888 (Cancer Institute and Hospital, Chinese Academy of Medical Sciences) shows an actual primary completion date on or before May 15, 2028. Registered date at generation: May 15, 2028.

Outcome verified from clinicaltrials.gov.

1. Market open

   Jul 17, 2026, 7:40 AM UTC
2. Market closes

   By May 15, 2028, 11:59 PM UTC
3. Projected payout

   Shortly after the market closes

Trading on material non-public information is prohibited. Markets are for entertainment and informational purposes using free Pulse Credits — no real-money wagering. If you believe a participant has acted on inside information, please report it.